We are thrilled to announce our first FDA 510(k) clearance for our digital precision medicine technology, TumorSight™! This milestone allows us to deliver on our vision to redefine precision medicine and revolutionize patient care. Read more here: businesswire.com/news/home/2…

We are excited to announce a strategic collaboration with the @MayoClinic for the development of novel digital medicine solutions for patients to help improve quality of life, starting with #breastcancer. Read more about this exciting collaboration here: businesswire.com/news/home/2…

As our product pipeline continues to advance, now is the perfect time to update our website to reflect all of our important progress! Learn more about the exciting things happening, including the latest on our TumorSight and PhenoScope platforms: simbiosys.com

As #BreastCancerAwarenessMonth ends, we reflect on how we can better serve patients so that they may live longer & better. Dr. Barry Rosen shares how recent tech, including our TumorSight platform, can help ensure that patients receive the best care. tinyurl.com/nhcajebd

🎗️Today, on #MetastaticBreastCancerAwarenessDay, we raise awareness for the thousands of individuals battling this chronic disease. SimBioSys is dedicated to helping to individualize care and improve outcomes. Learn more to #LightUpMBC: metavivor.org/take-action/ca…

If you’re attending the conference, please be sure to attend our presentation with Joseph Peterson on Friday and stop by Booth #1 to learn more about how PhenoScope™ Discovery can help uniquely advance your cancer research capabilities.

Join us at the Spatial Biology for Drug Development Summit to explore how this rapidly changing technology is becoming a crucial component of successful drug development programs and how we can help. Learn more: spatialbiology-drugdevelopme…

October is #BreastCancerAwarenessMonth. We've made much progress in treating this disease, but we can still do better. We’re developing our TumorSight technology to help doctors create treatment plans that are personalized for each patient – learn more: simbiosys.com/

Check out this recent @JournalofCP article by Matthew Biancalana and Tushar Pandey. They discuss how #AI can enhance the field of precision medicine and help unburden physicians from laborious and repetitive tasks in diagnostic analyses: hmpgloballearningnetwork.com…

This week CancerX announced its strategic priorities for 2023-2024 and its inaugural steering committee aligning their priorities with the broader Cancer Moonshot community. Learn about CancerX strategic priorities here: cancerx.health/about-cancerx…